gamma-Secretase Inhibitor II
200810-93-1
Yes
2026-11-14
Coenzymes,Inhibito,Enzymes,Zymogens,Substrates,Native Microorganism Creatine Amidinohydrolase
-
Product Description
-
Seller Information
-
Description
ProductName gamma-Secretase Inhibitor II Cat No CEI-0816 Alias MW167 Appearance Solid Molecular Weight 362.47 Synonyms MW167 Targets gamma-Secretase Molecular Formula C20H30N2O4 MDL Number MFCD03456910 Shipping Conditions Not regulated for shipping cas_num 200810-93-1 category Specialty Chemicals(c26) Research & Reference Notegamma-Secretase Inhibitor II is listed on ECHEMI for industrial / laboratory sourcing. This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Authoritative sourcesDisclaimer: This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Reviewed by ECHEMI Scientific Review - Platform editorial review for research chemicals
Basic Info-
Product Name:
gamma-Secretase Inhibitor II
Other Name:gamma-Secretase Inhibitor II;MW167;200810-93-1;methyl 2-[[2-[[2,2-difluoro-4-[[3-methyl-2-[[3-methyl-2-[(2-methylpropan-2-yl)oxycarbonylamino]butanoyl]amino]pentanoyl]amino]-3-oxopentanoyl]amino]-3-methylbutanoyl]amino]-3-methylpentanoate
CAS No.:200810-93-1
Molecular Formula:C33H57F2N5O9
InChIKeys:BZPZKKSYPNZRTG-UHFFFAOYSA-N
Exact Mass:705.41243474
Categories:
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Coenzymes,Inhibito,Enzymes,Zymogens,Substrates,Native Microorganism Creatine Amidinohydrolase
-
Location:
Shirley, New York 11967, USA
-
Payment Terms:
TT against copy of documents,D/P
-
Average lead Time:
15 days
-
Total Annual Revenue:
$1 million-$2.5 million
-
Year of Establishment:
2004
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product
